$74.08
-0.78-1.04%
At close: -
$74.02
-0.06-0.09%
After Hours: 4:20 PM EDT
Comments
Loading...
DuPont de Nemours Analyst Ratings and Price Targets | NYSE:DD | Benzinga
DuPont de Nemours Inc has a consensus price target of $87 based on the ratings of 21 analysts. The high is $112 issued by BMO Capital on February 13, 2025. The low is $73 issued by Barclays on April 29, 2025. The 3 most-recent analyst ratings were released by Mizuho, Wells Fargo, and Keybanc on July 15, 2025, July 14, 2025, and July 14, 2025, respectively. With an average price target of $87.33 between Mizuho, Wells Fargo, and Keybanc, there's an implied 17.99% upside for DuPont de Nemours Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Wells Fargo
Keybanc
UBS
JP Morgan
1calculated from analyst ratings
Analyst Ratings for DuPont de Nemours
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/15/2025 | 14.84% | Mizuho | $80 → $85 | Maintains | Outperform | |||
07/14/2025 | 21.6% | Wells Fargo | $81 → $90 | Maintains | Overweight | |||
07/14/2025 | 17.54% | Keybanc | $85 → $87 | Maintains | Overweight | |||
07/09/2025 | 17.54% | UBS | $85 → $87 | Maintains | Buy | |||
05/21/2025 | 14.84% | UBS | $79 → $85 | Maintains | Buy | |||
05/16/2025 | 25.65% | JP Morgan | $78 → $93 | Maintains | Overweight | |||
05/05/2025 | 14.84% | Keybanc | $81 → $85 | Maintains | Overweight | |||
05/05/2025 | 8.08% | Morgan Stanley | $94 → $80 | Maintains | Equal-Weight | |||
04/29/2025 | -1.37% | Barclays | $89 → $73 | Maintains | Equal-Weight | |||
04/24/2025 | 21.6% | RBC Capital | $101 → $90 | Maintains | Outperform | |||
04/15/2025 | 1.33% | B of A Securities | $80 → $75 | Upgrade | Underperform → Neutral | |||
04/15/2025 | 1.33% | UBS | $103 → $75 | Maintains | Buy | |||
04/15/2025 | 8.08% | Mizuho | $100 → $80 | Maintains | Outperform | |||
04/14/2025 | 9.44% | Keybanc | $81 → $81 | Upgrade | Sector Weight → Overweight | |||
04/09/2025 | 9.44% | Wells Fargo | $105 → $81 | Maintains | Overweight | |||
04/08/2025 | -0.02% | Citigroup | $95 → $74 | Maintains | Buy | |||
04/08/2025 | 2.68% | JP Morgan | $101 → $76 | Maintains | Overweight | |||
02/25/2025 | 39.16% | UBS | $102 → $103 | Maintains | Buy | |||
02/13/2025 | 28.35% | Citigroup | $88 → $95 | Maintains | Buy | |||
02/13/2025 | 51.32% | BMO Capital | $105 → $112 | Maintains | Outperform | |||
02/13/2025 | 20.24% | Barclays | $85 → $89 | Upgrade | Underweight → Equal-Weight | |||
02/12/2025 | 41.86% | Wells Fargo | $107 → $105 | Maintains | Overweight | |||
01/31/2025 | 18.89% | Citigroup | $92 → $88 | Maintains | Buy | |||
01/16/2025 | 41.86% | BMO Capital | $107 → $105 | Maintains | Outperform | |||
01/15/2025 | 36.46% | JP Morgan | $104 → $101 | Maintains | Overweight | |||
12/18/2024 | 24.3% | Citigroup | $98 → $92 | Maintains | Buy | |||
11/07/2024 | 40.51% | RBC Capital | $102 → $104 | Maintains | Outperform | |||
11/06/2024 | 44.56% | Wells Fargo | $105 → $107 | Maintains | Overweight | |||
11/06/2024 | 14.84% | Barclays | $84 → $85 | Maintains | Underweight | |||
10/21/2024 | 27% | Morgan Stanley | $88 → $94 | Maintains | Equal-Weight | |||
10/07/2024 | 13.49% | Barclays | $88 → $84 | Downgrade | Equal-Weight → Underweight | |||
08/05/2024 | 37.81% | RBC Capital | $87 → $102 | Maintains | Outperform | |||
08/01/2024 | 32.4% | Deutsche Bank | $92 → $98 | Maintains | Buy | |||
08/01/2024 | 18.89% | Barclays | $85 → $88 | Maintains | Equal-Weight | |||
07/12/2024 | 27% | Citigroup | $95 → $94 | Maintains | Buy | |||
05/29/2024 | 32.4% | UBS | $93 → $98 | Maintains | Buy | |||
05/28/2024 | 14.84% | Barclays | $81 → $85 | Maintains | Equal-Weight | |||
05/28/2024 | 28.35% | Citigroup | $85 → $95 | Upgrade | Neutral → Buy | |||
05/24/2024 | 29.7% | BMO Capital | $83 → $96 | Upgrade | Market Perform → Outperform | |||
05/24/2024 | 39.16% | Wells Fargo | $80 → $103 | Upgrade | Equal-Weight → Overweight | |||
05/23/2024 | 35.11% | Mizuho | $83 → $100 | Maintains | Buy | |||
05/17/2024 | 36.46% | Jefferies | $78 → $101 | Upgrade | Hold → Buy | |||
05/02/2024 | 18.89% | JP Morgan | $85 → $88 | Maintains | Overweight | |||
05/02/2024 | 9.44% | Barclays | $70 → $81 | Maintains | Equal-Weight | |||
05/02/2024 | 12.14% | Mizuho | $76 → $83 | Maintains | Buy | |||
04/11/2024 | 8.08% | Wells Fargo | $69 → $80 | Maintains | Equal-Weight | |||
04/10/2024 | 8.08% | Citigroup | $73 → $80 | Maintains | Neutral | |||
04/08/2024 | 12.14% | BMO Capital | $72 → $83 | Maintains | Market Perform | |||
03/22/2024 | 14.84% | JP Morgan | $76 → $85 | Maintains | Overweight | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
02/12/2024 | -5.43% | Barclays | $74 → $70 | Maintains | Equal-Weight | |||
02/07/2024 | 12.14% | RBC Capital | $75 → $83 | Maintains | Outperform | |||
02/07/2024 | 2.68% | Mizuho | $80 → $76 | Maintains | Buy | |||
01/25/2024 | 8.08% | Mizuho | $86 → $80 | Maintains | Buy | |||
01/25/2024 | -2.72% | BMO Capital | $80 → $72 | Downgrade | Outperform → Market Perform | |||
01/24/2024 | -6.78% | Wells Fargo | $85 → $69 | Downgrade | Overweight → Equal-Weight | |||
01/24/2024 | -2.72% | BMO Capital | $80 → $72 | Downgrade | Outperform → Market Perform | |||
01/16/2024 | 8.08% | B of A Securities | $78 → $80 | Downgrade | Buy → Underperform | |||
11/03/2023 | -0.02% | BMO Capital | $83 → $74 | Maintains | Outperform | |||
11/02/2023 | 14.84% | RBC Capital | $90 → $85 | Maintains | Outperform | |||
11/02/2023 | -0.02% | Barclays | $77 → $74 | Maintains | Equal-Weight | |||
10/04/2023 | 5.38% | Citigroup | $80 → $78 | Maintains | Neutral | |||
08/03/2023 | -1.37% | Morgan Stanley | $73 → $73 | Reiterates | Equal-Weight → Equal-Weight | |||
08/03/2023 | 21.6% | RBC Capital | $81 → $90 | Maintains | Outperform | |||
08/03/2023 | 16.19% | Mizuho | $81 → $86 | Maintains | Buy | |||
08/03/2023 | 4.03% | Barclays | $70 → $77 | Maintains | Equal-Weight | |||
07/20/2023 | 1.33% | Citigroup | $72 → $75 | Maintains | Neutral | |||
07/19/2023 | -1.37% | Morgan Stanley | $73 → $73 | Reiterates | Equal-Weight → Equal-Weight | |||
07/18/2023 | 8.08% | Wells Fargo | $75 → $80 | Maintains | Overweight | |||
07/11/2023 | -5.43% | Barclays | $72 → $70 | Maintains | Equal-Weight | |||
07/05/2023 | 9.44% | RBC Capital | $81 → $81 | Reiterates | Outperform → Outperform | |||
06/14/2023 | -2.72% | Citigroup | → $72 | Initiates | → Neutral | |||
05/15/2023 | 8.08% | Deutsche Bank | $70 → $80 | Upgrade | Hold → Buy | |||
05/04/2023 | 9.44% | RBC Capital | $92 → $81 | Maintains | Outperform | |||
05/04/2023 | -1.37% | Morgan Stanley | $79 → $73 | Maintains | Equal-Weight | |||
05/03/2023 | -5.43% | Deutsche Bank | $82 → $70 | Maintains | Hold | |||
05/03/2023 | 13.49% | BMO Capital | $103 → $84 | Maintains | Outperform | |||
05/03/2023 | 1.33% | Wells Fargo | $85 → $75 | Maintains | Overweight | |||
05/03/2023 | 9.44% | Mizuho | $85 → $81 | Maintains | Buy | |||
05/03/2023 | -2.72% | Barclays | $76 → $72 | Maintains | Equal-Weight | |||
04/10/2023 | 2.68% | Barclays | $80 → $76 | Maintains | Equal-Weight | |||
02/09/2023 | 10.79% | Deutsche Bank | $80 → $82 | Maintains | Hold | |||
02/09/2023 | 24.3% | RBC Capital | $85 → $92 | Maintains | Outperform | |||
02/08/2023 | 6.73% | Morgan Stanley | $72 → $79 | Maintains | Equal-Weight | |||
02/08/2023 | 20.24% | Citigroup | $82 → $89 | Maintains | Buy | |||
02/08/2023 | 14.84% | Wells Fargo | $77 → $85 | Maintains | Overweight | |||
02/08/2023 | 14.84% | Mizuho | $83 → $85 | Maintains | Buy | |||
02/08/2023 | 8.08% | Barclays | $71 → $80 | Maintains | Equal-Weight | |||
01/17/2023 | 8.08% | Deutsche Bank | $75 → $80 | Downgrade | Buy → Hold | |||
01/12/2023 | 12.14% | Mizuho | $82 → $83 | Maintains | Buy | |||
01/12/2023 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
12/15/2022 | 10.79% | Citigroup | $75 → $82 | Maintains | Buy | |||
11/09/2022 | 2.68% | RBC Capital | $64 → $76 | Maintains | Outperform | |||
11/09/2022 | 4.03% | Wells Fargo | $60 → $77 | Maintains | Overweight | |||
11/09/2022 | 18.89% | BMO Capital | $80 → $88 | Maintains | Outperform | |||
11/09/2022 | 1.33% | Credit Suisse | $64 → $75 | Maintains | Outperform | |||
10/20/2022 | 6.73% | Mizuho | $93 → $79 | Maintains | Buy | |||
10/18/2022 | -18.94% | Wells Fargo | $72 → $60 | Maintains | Overweight | |||
10/04/2022 | 8.08% | Keybanc | $82 → $80 | Maintains | Overweight | |||
10/03/2022 | -18.94% | Deutsche Bank | $70 → $60 | Maintains | Buy |
FAQ
What is the target price for DuPont de Nemours (DD) stock?
The latest price target for DuPont de Nemours (NYSE:DD) was reported by Mizuho on July 15, 2025. The analyst firm set a price target for $85.00 expecting DD to rise to within 12 months (a possible 14.84% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DuPont de Nemours (DD)?
The latest analyst rating for DuPont de Nemours (NYSE:DD) was provided by Mizuho, and DuPont de Nemours maintained their outperform rating.
When was the last upgrade for DuPont de Nemours (DD)?
The last upgrade for DuPont de Nemours Inc happened on April 15, 2025 when B of A Securities raised their price target to $75. B of A Securities previously had an underperform for DuPont de Nemours Inc.
When was the last downgrade for DuPont de Nemours (DD)?
The last downgrade for DuPont de Nemours Inc happened on October 7, 2024 when Barclays changed their price target from $88 to $84 for DuPont de Nemours Inc.
When is the next analyst rating going to be posted or updated for DuPont de Nemours (DD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DuPont de Nemours, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DuPont de Nemours was filed on July 15, 2025 so you should expect the next rating to be made available sometime around July 15, 2026.
Is the Analyst Rating DuPont de Nemours (DD) correct?
While ratings are subjective and will change, the latest DuPont de Nemours (DD) rating was a maintained with a price target of $80.00 to $85.00. The current price DuPont de Nemours (DD) is trading at is $74.02, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
